Suppr超能文献

肝脏肿瘤手术

Surgery of liver tumours.

作者信息

Guest J, Blumgart L H

出版信息

Baillieres Clin Gastroenterol. 1987 Jan;1(1):131-50. doi: 10.1016/0950-3528(87)90037-6.

Abstract

The liver is a segmental organ that allows resection through anatomically defined planes. The surgical management of an intrahepatic lesion, discovered either during investigation of hepatological symptoms or coincidentally, must involve an approach to investigation that carries a minimum risk and does not compromise subsequent excision of the lesion. Biopsy of an intrahepatic lesion found at laparotomy is essential, but attempts at early tissue diagnosis by percutaneous biopsy of operable tumours may lead to unnecessary morbidity and tumour spread. Preoperative studies often allow a firm pathological diagnosis to be made and ultrasonography, CT scanning and arteriography can be used to fully assess operability. Hepatocellular carcinoma (HCC) is the commonest primary liver cancer and is often found in association with cirrhosis and in patients with inadequate functional hepatic reserve. Surgical excision represents the only hope of cure for these patients and a 35% 5-year survival can be achieved by resection in the non-cirrhotic patient. Fibrolamellar HCC is less often associated with cirrhosis and is more often resectable with a better prognosis. Secondary tumours are often diffuse but about 5% of colorectal metastases are either solitary or confined to a resectable area of the liver. These tumours and secondary deposits from gastrointestinal endocrine tumours represent a small group of patients with potentially curable metastatic disease. Morbidity and mortality of operation depends on the extent of resection and the functional reserve of the liver. Local resections and resection for benign disease should carry no operative mortality. Major hepatic resection has a mortality of 3-5% and resection involving the structures at the hilus of the liver has an operative mortality of 10-12%. Liver transplantation in the management of neoplastic disease in the liver has yet to show any benefit over resectional surgery except where tumours have been discovered incidentally in the removed liver after transplantation for cirrhosis.

摘要

肝脏是一个节段性器官,可通过解剖学上明确的平面进行切除。无论是在肝病症状检查期间发现还是偶然发现的肝内病变,其手术治疗都必须采用风险最小且不影响后续病变切除的检查方法。剖腹手术时发现的肝内病变活检至关重要,但对可手术切除的肿瘤进行经皮活检以进行早期组织诊断的尝试可能会导致不必要的发病率和肿瘤扩散。术前研究通常能做出明确的病理诊断,超声、CT扫描和动脉造影可用于全面评估手术可行性。肝细胞癌(HCC)是最常见的原发性肝癌,常与肝硬化相关,且见于肝功能储备不足的患者。手术切除是这些患者唯一的治愈希望,非肝硬化患者切除术后5年生存率可达35%。纤维板层样HCC较少与肝硬化相关,更常可切除,预后较好。继发性肿瘤通常是弥漫性的,但约5%的结直肠癌转移灶要么是孤立的,要么局限于肝脏的可切除区域。这些肿瘤以及胃肠道内分泌肿瘤的继发性沉积物代表了一小部分具有潜在可治愈转移性疾病的患者。手术的发病率和死亡率取决于切除范围和肝脏的功能储备。局部切除和良性疾病切除不应有手术死亡率。肝大部切除的死亡率为3 - 5%,涉及肝门结构的切除手术死亡率为10 - 12%。在肝脏肿瘤性疾病的治疗中,肝移植除了在因肝硬化进行移植后切除的肝脏中偶然发现肿瘤外,尚未显示出比切除手术有任何优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验